Shannon T Kelley
General Counsel at Madrigal Pharmaceuticals, Inc. (MDGL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $842K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 66411,474 held (−5%) | $514.97 | $342K | -12.7% |
| Mar 6SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 36012,138 held (−3%) | $431.94 | $155K | +4.1% |
| Jan 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 2638,910 held (−3%) | $490.77 | $129K | -8.4% |
| Jan 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 4298,481 held (−5%) | $501.40 | $215K | -10.3% |
- Sell
General Counsel Shannon T Kelley sold $129K of MDGL at $490.77 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Shannon T Kelley sold $215K of MDGL at $501.40 — pre-scheduled 10b5-1 plan sale.